
|Articles|July 31, 2017
Schulman IRB Launches Central Neurology Review Service
Advertisement
Schulman IRB-an industry IRB in customer service and technology-announced the launch of its Central Neurology Review (CNR) service.
Through its partnership with the National Biomedical Research Ethics Council (NBREC), a 501(c) non-profit, Schulman developed CNR to assist research institutions and biopharma and device companies.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Takeda’s Phase III TIDES Trial Confirms Long-Term Efficacy and Safety of Qdenga Dengue Vaccine
2
Streamlining Clinical Data to Reduce Site and Participant Burden
3
Utilizing Tech Tools to Accelerate Drug Development
4
ACT Brief: Lilly Seeks FDA Priority Review for Oral GLP-1 as Bispecific Antibody Trials Redefine Ethical Standards
5






.png)



.png)



.png)
.png)
